| Literature DB >> 24005854 |
Hadi Zare-Zardini1, Behnaz Tolueinia, Azam Hashemi, Leila Ebrahimi, Farzaneh Fesahat.
Abstract
Antioxidant agents and cholinesterase inhibitors are the foremost drugs for the treatment of Alzheimer's disease (AD). In this study, a new peptide from Ziziphus jujuba fruits was investigated for its inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes as well as antioxidant activity. This peptide was introduced as a new peptide and named Snakin-Z. The Snakin-Z displayed considerable cholinesterase inhibition against AChE and BChE. The half maximal inhibitory concentration (IC50) values of Snakin-Z against AChE and BChE are 0.58 ± 0.08 and 0.72 ± 0.085 mg/mL, respectively. This peptide has 80% enzyme inhibitory activity on AChE and BChE at 1.5 mg/mL. The Snakin-Z also had the high antioxidant activity (IC50 = 0.75 ± 0.09 mg/mL). Thus, it is suggested that Snakin-Z may be beneficial in the treatment of AD. However, more detailed researches are still required as in vivo testing its anticholinesterase and antioxidant activities.Entities:
Keywords: Alzheimer’s disease; Ziziphus jujuba fruits; acetylcholinesterase; antioxidant; butyrylcholinesterase
Mesh:
Substances:
Year: 2013 PMID: 24005854 DOI: 10.1177/1533317513500839
Source DB: PubMed Journal: Am J Alzheimers Dis Other Demen ISSN: 1533-3175 Impact factor: 2.035